Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 31, 2008Cancer ResearchOpen Access

Mutations in the Phosphatidylinositol-3-Kinase Pathway Predict for Antitumor Activity of the Inhibitor PX-866 whereas Oncogenic Ras Is a Dominant Predictor for Resistance

View Full Paper
Ask AI
Bookmark
Share

Authors

NINathan T. IhleThe University of Texas MD Anderson Cancer CenterRLRobert LemosTranslational Genomics Research InstitutePWPeter WipfRutgers, The State University of New Jersey

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Ihle et al. (2008) studied this question.

synapsesocial.com/papers/6a09713edd65a80ea2511e42https://doi.org/10.1158/0008-5472.can-07-6656
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Nerve growth factor promotes the activation of phosphatidylinositol 3-kinase and its association with the trk tyrosine kinase.1992 · 243 citations
  2. 2Synthesis and biological evaluation of synthetic viridins derived from C(20)-heteroalkylation of the steroidal PI-3-kinase inhibitor wortmannin2004 · 78 citations
  3. 3Distinct requirements for Ras oncogenesis in human versus mouse cells2002 · 426 citations
  4. 4<i>KRAS</i>Mutation Is an Important Predictor of Resistance to Therapy with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non–Small-Cell Lung Cancer2007 · 600 citations
  5. 5K-Ras Promotes Growth Transformation and Invasion of Immortalized Human Pancreatic Cells by Raf and Phosphatidylinositol 3-Kinase Signaling2007 · 225 citations